Industry reports
Editor highlights

US Nanotechnology in Health Care Market Focus report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Surgical Meshes (Synthetic) for Female Stress Urinary Incontinence - Medical Device Safety and Approval Report - Comprehensive

Surgical Meshes (Synthetic) for Female Stress Urinary Incontinence - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • by DeviceMatters
  • April 2014
  • 48 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Surgical Meshes (Synthetic) for Female Stress Urinary Incontinence, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure ...

Industries: Pathology | Countries: United States

Gynecologic Surgical Meshes for Female Stress Urinary Incontinence - Medical Device Safety and Approval Report - Comprehensive

Gynecologic Surgical Meshes for Female Stress Urinary Incontinence - Medical Device Safety and Approval Report - Comprehensive

  • $ 199
  • Industry report
  • by DeviceMatters
  • April 2014
  • 67 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Gynecologic Surgical Meshes for Female Stress Urinary Incontinence, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure ...

Industries: Pathology | Countries: United States

Surgical Meshes for Male Stress Urinary Incontinence - Medical Device Safety and Approval Report - Comprehensive

Surgical Meshes for Male Stress Urinary Incontinence - Medical Device Safety and Approval Report - Comprehensive

  • $ 149
  • Industry report
  • by DeviceMatters
  • April 2014
  • 41 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of Surgical Meshes for Male Stress Urinary Incontinence, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure modes. This ...

Industries: Pathology | Countries: United States

CPR/Physical Cardiovascular Aids - Medical Device Safety and Approval Report - Comprehensive

CPR/Physical Cardiovascular Aids - Medical Device Safety and Approval Report - Comprehensive

  • $ 399
  • Industry report
  • by DeviceMatters
  • April 2014
  • 74 pages

The comprehensive DeviceMatters medical device safety and approval report provides an overview of CPR/Physical Cardiovascular Aids, recent device approvals, supplements, recalls, and in-depth review of adverse event trends and insights including specific device failure modes. This 798kb pdf report is ...

Industries: Pathology | Countries: United States

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • April 2014
  • 49 pages

EpiCast Report: Allergic Rhinitis - Epidemiology Forecast to 2023 Summary Allergic rhinitis is a chronic respiratory disease characterized by inflammation of the nasal cavity and affects people of all ages. The main symptoms of allergic rhinitis are sneezing, nasal itching, blocked or runny nose and ...

Industries: Pathology | Countries: Japan, World, Spain, Italy, France, Germany, United States, United Kingdom

Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight

Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight

  • $ 5 619
  • Industry report
  • by Firstword Pharma
  • April 2014
  • 163 pages

Approval of Gilead's once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in class therapy represents a paradigm shift compared to the protease inhibitors and interferon regimens. With ...

Industries: Pathology | Countries: United States

Vital Signs - Healthcare News - The Analyst%s Perspect March 2014 Issue

Vital Signs - Healthcare News - The Analyst%s Perspect March 2014 Issue

  • $ 450
  • Industry report
  • by Frost & Sullivan
  • March 2014
  • 5 pages

This issue of Vital Signs, released on March 31, 2014, discusses the premium price tag of Gilead's Sovaldi, Sony's genomic partnership with Illumina, and Craig Venter's latest venture, Human Longevity, Inc. LIFE SCIENCES A panel of experts convened in San Francisco, Calif., to discuss the cost-effectiveness ...

Industries: Pathology | Countries: United States

Binge Eating Disorder - Pipeline Review, H1 2014

Binge Eating Disorder - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • March 2014
  • 56 pages

Binge Eating Disorder - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Binge Eating Disorder - Pipeline Review, H1 2014', provides an overview of the Binge Eating Disorder's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Binge Eating ...

Industries: Pathology | Countries: World, United States

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2014

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • March 2014
  • 75 pages

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2014', provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF)'s therapeutic pipeline. This report provides ...

Industries: Pathology | Countries: World, United States

Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2014

Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • by Global Markets Direct
  • March 2014
  • 50 pages

Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2014', provides an overview of the Herpes Labialis (Oral Herpes)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development ...

Industries: Pathology | Countries: World, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 917 267 7886

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.